BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 10555220)

  • 1. [Epidemiology of familial prostatic cancer: 4-year assessment of French studies].
    Valeri A; Drelon E; Azzouzi R; Delannoy A; Teillac P; Fournier G; Mangin P; Berthon P; Cussenot O
    Prog Urol; 1999 Sep; 9(4):672-9. PubMed ID: 10555220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic, epidemiologic and clinical study of familial prostate cancer].
    Valéri A
    Bull Acad Natl Med; 2002; 186(4):779-88; discussion 788-91. PubMed ID: 12412374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The PROGENE study, the French project of genetic analysis of familial prostatic cancer: recruitment and analysis].
    Valeri A; Berthon P; Fournier G; Buzzi JC; Briollais L; Meria P; Blanche H; Bellanne-Chantelot C; Teillac P; Demenais F; Mangin P; Cohen N; Le Duc A; Cussenot O
    Prog Urol; 1996 Apr; 6(2):226-35. PubMed ID: 8777415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic analysis of familial prostatic cancer: localization of a gene predisposing to prostatic cancer (PCaP) on chromosome 1q 42.2-43].
    Valeri A; Drelon E; Paiss T; Vogel W; de Petriconi R; Hautmann R; Fournier G; Mangin P; Berthon P; Cussenot O
    Prog Urol; 1999 Sep; 9(4):680-8. PubMed ID: 10555221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary aspects of prostate cancer.
    McLellan DL; Norman RW
    CMAJ; 1995 Oct; 153(7):895-900. PubMed ID: 7553490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segregation analysis of 389 Icelandic pedigrees with Breast and prostate cancer.
    Baffoe-Bonnie AB; Kiemeney LA; Beaty TH; Bailey-Wilson JE; Schnell AH; Sigvaldason H; Olafsdóttir G; Tryggvadóttir L; Tulinius H
    Genet Epidemiol; 2002 Nov; 23(4):349-63. PubMed ID: 12432503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy.
    Siddiqui SA; Sengupta S; Slezak JM; Bergstralh EJ; Zincke H; Blute ML
    J Urol; 2006 Sep; 176(3):1118-21. PubMed ID: 16890705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic susceptibility to prostate cancer].
    Cussenot O; Cancel-Tassin G
    Med Sci (Paris); 2004 May; 20(5):562-8. PubMed ID: 15190476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing age at prostate cancer diagnosis over successive generations in prostate cancer families.
    Bock CH; Peyser PA; Montie JE; Cooney KA
    Prostate; 2005 Jun; 64(1):60-6. PubMed ID: 15651090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characterisation of families with hereditary prostate cancer in the Netherlands].
    Meulenbeld HJ; Verhage BA; Kil PJ; Kiemeney LA; Vasen HF
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1938-42. PubMed ID: 12404910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age at diagnosis and age at death in familial prostate cancer.
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Oncologist; 2009 Dec; 14(12):1209-17. PubMed ID: 19939895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary/familial versus sporadic prostate cancer: few indisputable genetic differences and many similar clinicopathological features.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2010 Jan; 14(1):31-41. PubMed ID: 20184087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial risk of cancer shortly after diagnosis of the first familial tumor.
    Bermejo JL; Hemminki K
    J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome after radical prostatectomy in young men with or without a family history of prostate cancer.
    Rouprêt M; Fromont G; Bitker MO; Gattegno B; Vallancien G; Cussenot O
    Urology; 2006 May; 67(5):1028-32. PubMed ID: 16698363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age specific risks of familial prostate carcinoma: a basis for screening recommendations in high risk populations.
    Grönberg H; Wiklund F; Damber JE
    Cancer; 1999 Aug; 86(3):477-83. PubMed ID: 10430256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk for smoking-related cancer among relatives of lung cancer patients.
    Etzel CJ; Amos CI; Spitz MR
    Cancer Res; 2003 Dec; 63(23):8531-5. PubMed ID: 14679021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher frequency of familial clustering of prostate cancer in French-Canadian men.
    Filion E; Taussky D; Bahary JP; Maugard CM
    J Urol; 2007 Oct; 178(4 Pt 1):1265-9; discussion 1270. PubMed ID: 17698103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and histopathological characteristics of familial prostate cancer in Finland.
    Pakkanen S; Kujala PM; Ha N; Matikainen MP; Schleutker J; Tammela TL
    BJU Int; 2012 Feb; 109(4):557-63. PubMed ID: 21507186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families.
    Xu J; Gillanders EM; Isaacs SD; Chang BL; Wiley KE; Zheng SL; Jones M; Gildea D; Riedesel E; Albertus J; Freas-Lutz D; Markey C; Meyers DA; Walsh PC; Trent JM; Isaacs WB
    Prostate; 2003 Dec; 57(4):320-5. PubMed ID: 14601028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.